DRI Healthcare Trust's CEO, Behzad Khosrowshahi, resigned amidst an investigation into alleged expense irregularities, causing shares to plummet 32%.

Pharma company DRI Healthcare Trust's shares plunged 32% after its CEO, Behzad Khosrowshahi, resigned following an investigation into alleged irregularities related to consulting and other expenses. CFO Chris Anastasopoulos was suspended with pay pending the outcome of the probe. The board has appointed Gary Collins, former politician in British Columbia, as interim CEO.

Articles

BNN Bloomberg

Pique Newsmagazine

medicinehatnews.com

World News

Airdrie City View

CityNews Toronto

Winnipeg Free Press

BNN Bloomberg

-- show less --

Related Stories